Deborah Watkins Bruner

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell et al. · JNCI Journal of the National Cancer Institute · 2014 · 1.1K citations · Full text

Pharmacy, Oncology, Cancer Control +15

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell et al. · JAMA Oncology · 2015 · 1K citations · Full text

Pharmacy, Oncology, Outcomes Research +13

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

Paul D. Brown, S. Pugh, Nadia N. Laack et al. · Neuro-Oncology · 2013 · 944 citations · Full text

Medicine, Pharmacotherapy, Radiation Oncology +17

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al. · Journal of Clinical Oncology · 2020 · 830 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases

William F. Hartsell, Charles Scott, Deborah Watkins Bruner et al. · JNCI Journal of the National Cancer Institute · 2005 · 828 citations · Full text

Medicine, Oncology, Radiation Oncology +14